Journals / Ağrı / 2014 / Cilt: 26 - Sayı: 3

Olgu sunumu: İndometazine dirençli hemicrania continua mı yoksa yeni bir başağrısı mı?

A case report: indomethacin resistance hemicrania continua or a new entity?

Journal
Ağrı
Pages
138–140
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Pregabalin may be an effective treatment for hemicrania continua in some patients with indomethacin resistance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hemicrania continua (HC) is a rare primary headache disorder.
📊
Key Findings & Data:It presents some autonomic features (including conjunctival injection, ptosis, eyelid edema, lacrimation, nasal congestion, and rhinorrhea).
💡
Conclusion & Impact:Pregabalin may be an effective treatment for hemicrania continua in some patients with indomethacin resistance.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hemicrania continua (HC) is a rare primary headache disorder. It presents some autonomic features (including conjunctival injection, ptosis, eyelid edema, lacrimation, nasal congestion, and rhinorrhea). Response to indomethacin treatment is the mandatory criteria for the diagnosis of HC. However, previously reported literature indicates that there are some reported cases that did not respond to indomethacin. In this case report, we present a patient who had indomethacin resistance with an associated pregabalin response. Pregabalin may be an effective treatment for hemicrania continua in some patients with indomethacin resistance.

Özet

Hemicrania continua (HC) nadir primer başağrısıdır. Bazı otonomik bulgularla birliktedir (konjunktival yaşarma, pitoz, gözkapağı ödemi, lakrimasyon, nazal konjesyon, rinore gibi). HC tanısı için indometazin tedavisine yanıt zorunlu tanı kriteridir. Bununla birlikte literatürde indometazine yanıt vermeyen olgular bildirilmiştir. Bu yazıda, indometazin yanıtı olmayan ancak pregabalin tedavisine yanıt veren bir olgu sunuldu. Pregabalin indometazine dirençli HC başağrısında bazı hastalar için etkili bir tedavi alternatifi olabilir.

🔖

Cite This Article

COŞKUN, Ö., ÜÇLER, S., İNAN, L. E., ÖCAL, R. (2014). Olgu sunumu: İndometazine dirençli hemicrania continua mı yoksa yeni bir başağrısı mı?. Ağrı, Cilt: 26 - Sayı: 3, 138–140. https://ajindex.com/articles/160546

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. P rakash S, Husain M, Sureka DS, Shah NP, Shah ND. Is there need to search for alternatives to indomethacin for hemi- crania continua? Case reports and a review. J Neurol Sci 2009;277(1-2):187-90
  2. Headache Classification Committee of the International Headache Society. The International Classification of Head- ache Disorders: 2nd edition. Cephalalgia 2004;24 Suppl 1:9- 160
  3. M ariano Da Silva H, Alcantara MC, Bordini CA, Speciali JG. Strictly unilateral headache reminiscent of hemicrania con- tinua resistant to indomethacin but responsive to gabapen- tin. Cephalalgia 2002;22(5):409-10
  4. P rakash S, Shah ND, Bhanvadia RJ. Hemicrania continua un- responsive or partially responsive to indomethacin: does it exist? A diagnostic and therapeutic dilemma. J Headache Pain 2009;10(1):59-63
  5. S jaastad O, Spierings EL. “Hemicrania continua”: another headache absolutely responsive to indomethacin. Cephalal- gia 1984;4(1):65-70
  6. Spears RC. Is gabapentin an effective treatment choice for hemicrania continua? J Headache Pain 2009;10(4):271-5
  7. M atharu MS, Goadsby PJ. Functional brain imaging in hemi- crania continua: implications for nosology and pathophysi- ology. Curr Pain Headache Rep 2005;9(4):281-8
  8. P izzolato R, Villani V, Prosperini L, Ciuffoli A, Sette G. Effi- cacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up study. J Headache Pain 2011;12(5):521-5
  9. T assone DM, Boyce E, Guyer J, Nuzum D. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disor- ders. Clin Ther 2007;29(1):26-48
  10. B en-Menachem E. Pregabalin pharmacology and its rel- evance to clinical practice. Epilepsia 2004;45 Suppl 6: